Advertisement
Screener

Monopar Therapeutics Inc. (MNPR) Market Cap

Monopar Therapeutics Inc. (MNPR) Market Cap

  • 2026-09-03: Market Cap $795.16M.
  • 2026-07-31: Market Cap $727.26M.
  • 2026-06-30: Market Cap $621.48M.
  • 2026-04-30: Market Cap $349.36M.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2019-12-31 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$795.16M
2026-07-31$727.26M
2026-06-30$621.48M
2026-04-30$349.36M
2026-03-31$367.04M
2026-03-17$403.34M
2025-12-31$437M
2025-10-31$575.77M
2025-09-30$544.16M
2025-07-31$254.08M
2025-06-30$219.24M
2025-04-30$255.74M
2025-03-31$222.65M
2025-03-14$181.85M
2024-12-31$134.26M
2024-10-31$76.9M
2024-09-30$23.76M
2024-07-31$61.61M
2024-06-30$64.25M
2024-04-30$57.7M
2024-03-31$59.53M
2024-03-08$71.3M
2023-12-31$5.07M
2023-11-07$28.99M
2023-09-30$44.02M
2023-07-28$51.89M
2023-06-30$59.41M
2023-04-28$74.37M
2023-03-31$91.89M
2023-03-10$179.89M
2022-12-31$153.42M
2022-10-31$158.13M
2022-09-30$97.7M
2022-07-29$124.71M
2022-06-30$146.06M
2022-04-30$143.89M
2022-03-31$160.91M
2022-03-11$185.29M
2021-12-31$202.2M
2021-10-31$302.17M
2021-09-30$306.58M
2021-07-31$334.07M
2021-06-30$370.56M
2021-04-30$377.73M
2021-03-31$389.67M
2021-03-05$391.46M
2020-12-31$350.48M
2020-10-31$254.24M
2020-09-30$306.52M
2020-07-31$394.03M
2020-06-30$400.45M
2020-05-01$380.17M
2020-03-31$380.56M
2020-03-13$340.42M
2019-12-31$878.77M

Similar stocks

Stock NameCountryMarket CapPE Ratio
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B